Wondering what the future holds for the ever-changing medspa industry? Curious how you can take advantage of current industry trends? We recently spoke with our co-founder and CEO Francis X. Acunzo about his thoughts regarding the top three medspa trends we will be seeing in 2024: 1. Weight loss programs: Semaglutide We are seeing more Continue Reading…
Site Selection Analysis
Acara Partners provides full-service consulting to physicians, medical providers and entrepreneurs to develop successful aesthetic medical practices nationwide. With a methodical approach, our team of business development experts guide our clients in every step of the medspa development process — from concept development to open doors. After the medspa concept is developed, our consulting team Continue Reading…
Sciton Rockstar Experience is Coming to Boston
Sciton Rockstar Experience is coming to the east coast! Join Acara Partners’ co-founder and CEO and Princeton Medspa Partners’ President, Francis Acunzo, alongside aesthetic medical industry leaders, March 25-26 at Boston Marriott Cambridge. Francis Acunzo will be leading a presentation on ‘Aesthetic Market Trends.’ This two-day educational event will include “cutting-edge clinical applications, advanced treatment Continue Reading…
Acara’s Founders Talk ‘Botox’ with NPR’s “The Pulse”
Acara Partners’ co-founders, Colleen and Francis Acunzo, sat down with Grant Hill of NPR WHYY’s “The Pulse” for an exciting exploratory conversation about all things Botox®. Tune in to the podcast or read the article to learn about the Acunzo’s vision behind the first medical spa in the late 90’s and hear how Botox’s impact Continue Reading…
Las Vegas Here We Come!
Acara Partners will exhibit at The Medical Spa Show 2023 at Wynn Las Vegas, February 2-5, 2023. The Acara team is excited to see clients and industry friends at AmSpa’s annual event. Members of the consulting and marketing team will be available at Acara Partners’ Booth #230. In addition to exhibiting as a proud vendor Continue Reading…
Acara Partners’ CEO to Speak at The Medical Spa Show 2023
Las Vegas, here we come! Acara Partners will be exhibiting at The Medical Spa Show 2023, presented by AmSpa (American Med Spa Association), February 2-5, 2023. Our co-founder and CEO, Francis Acunzo, will lead an ‘Advanced Business’ Session. Join us on Friday, February 3, 2023, from 2:15 – 2:40 p.m. for our exciting educational session Continue Reading…
FDA Approves Daxxify, a Botox Competitor
Big news for medspa owners and patients: DAXXIFY™ (DaxibotulinumtoxinA-lanm), a rival of Botox®, was approved by the FDA on September 7, 2022. Like its competitor, Botox, Daxxify is a facial injection for the “temporary improvement of moderate to severe frown lines (glabellar lines) in adults.”- Daxxify. The Wall Street Journal says, “Analysts say the drug, Continue Reading…
Sciton’s Rockstars of Aesthetics Event: Coming to New York, September 17-18
Acara Partners will be joining Sciton in NYC this September for two full days of clinical demos, advanced treatment techniques and emerging industry trends. Thought leaders and critically acclaimed dermatologists, plastic surgeons and industry partners will be in attendance for a weekend jam packed with demos of the hottest technologies, presentations of best practices of Continue Reading…
Allergan Announces FDA Approval of JUVÉDERM® VOLUX™ XC
Last week, Allergan made an exciting announcement that the FDA has approved JUVÉDERM® VOLUX™ XC! This FDA approval is major news for the aesthetic medical industry because JUVÉDERM VOLUX XC is the first and only hyaluronic acid (HA) filler for improving jawline definition to be approved by the FDA. Acara Partners is excited to learn Continue Reading…
Acara’s Consultants Contribute to MedEsthetics’ January/February Issue
Nina Balan, senior business consultant, and Angela Taylor, vice president of Practice Development & Consulting at Acara Partners, have contributed to MedEsthetics in a new article titled, “Make Retail Sales a Vital Part of Your Business.” Look out for the January/February 2022 issue in your mailbox this week. For those that are not yet subscribed Continue Reading…